Genomic Valley Stock Price Analysis and Quick Research Report. Is Genomic Valley an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Genomic Valley stock price today is Rs 100.75. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Genomic Valley . 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Genomic Valley has a PE ratio of 121.151996151996 which is high and comparatively overvalued .

• Share Price: - The current share price of Genomic Valley is Rs 100.75. One can use valuation calculators of ticker to know if Genomic Valley share price is undervalued or overvalued.

• Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Genomic Valley has ROA of 15.7775465238897 % which is a good sign for future performance. (higher values are always desirable)

• Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Genomic Valley has a Current ratio of 2.88501919634181 .

• Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Genomic Valley has a ROE of 20.2405322611302 % .(higher is better)

• Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Genomic Valley has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

• Sales growth: - Genomic Valley has reported revenue growth of 3758.22657445723 % which is fair in relation to its growth and performance. 

• Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Genomic Valley for the current financial year is 32.3762699176755 %.

• Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Genomic Valley is Rs 0 and the yield is 0 %.

• Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Genomic Valley is Rs 0.8316 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Genomic Valley in Ticker for free. Also, one can get the intrinsic value of Genomic Valley by using Valuation Calculators, which are available with a Finology ONE subscription.